Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Innoryos
- Development stage
- Phase 3
- Lead developer
- ALBOMED
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intraarticular
01
Overview
Innoryos is a viscoelastic medical product developed by ALBOMED GmbH for the treatment of joint osteoarthritis, specifically knee osteoarthritis. It is a combination formulation consisting of bacterial-derived sodium hyaluronate (hyaluronic acid) and niacinamide (15mg). The hyaluronic acid component acts as a viscosupplement to restore the rheological properties of synovial fluid, providing lubrication and shock absorption within the joint. Niacinamide is included for its anti-inflammatory properties, which may help mitigate degenerative processes in arthritic joints. The product is administered via intra-articular injection and has been studied in both single-injection (2.5% concentration) and triple-injection (2.2% concentration) protocols for patients with moderate to severe knee osteoarthritis.
- Brand names
- Innoryos
- Other names
- Innoryos 2.2%Innoryos 2.5%
02
Targets
CD44 (CD44 antigen)
Beyond the preview
Go deeper on Innoryos.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innoryos.